BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3786928)

  • 1. [Diffusion of trimethoprim and sulfamethoxazole into the pleural fluid].
    Varoquaux O; Kasparian P; Pieplu C; Brion N; Guibout P; Pays M; Advenier C
    Rev Mal Respir; 1986; 3(4):213-7. PubMed ID: 3786928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lung tissue diffusion of intravenous trimethoprim-sulfamethoxazole combination (author's transl)].
    Morel C; Langeard M; Vergnaud M; Monrocq N
    Pathol Biol (Paris); 1982 Jun; 30(6):380-4. PubMed ID: 7050846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of pharmacokinetics of the combination trimethoprim and sulfamethoxazole in patients with liver diseases and healthy persons].
    Rieder VJ; Schwartz DE
    Arzneimittelforschung; 1975 Apr; 25(4):656-66. PubMed ID: 1174084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone diffusion of trimethoprim and sulfamethoxazole high pressure liquid chromatography (HPLC) (author's transl)].
    Saux MC; Le Rebeller A; Leng B; Mintrosse J
    Pathol Biol (Paris); 1982 Jun; 30(6):385-8. PubMed ID: 7050847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Co-trimoxazole concentration in the prostatic fluid of patients with subacute and chronic prostatitis].
    Hofstetter A; Friesen A; Bishop-Freudling GB; Vergin H
    Fortschr Med; 1984 Mar; 102(9):244-6. PubMed ID: 6608482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thiamphenicol versus trimethoprim-sulfamethoxazole in bacterial exacerbations of chronic unspecific respiratory tract diseases. A controlled study].
    Medici TC; Hermann R; Lualdi P; Frigerio G
    Schweiz Med Wochenschr; 1980 Jul; 110(30):1128-37. PubMed ID: 6999618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on cerebrospinal fluid diffusion of trimethoprim in children].
    Fries N; Keuth U; Braun JS
    Fortschr Med; 1975 Sep; 93(25):1178-83. PubMed ID: 1213643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
    Singlas E; Colin JN; Rottembourg J; Meessen JP; de Martin A; Legrain M; Simon P
    Eur J Clin Pharmacol; 1982; 21(5):409-15. PubMed ID: 7075646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.
    Siber GR; Gorham CC; Ericson JF; Smith AL
    Rev Infect Dis; 1982; 4(2):566-78. PubMed ID: 6981173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media. Greater Boston Otitis Media Study Group.
    Barnett ED; Teele DW; Klein JO; Cabral HJ; Kharasch SJ
    Pediatrics; 1997 Jan; 99(1):23-8. PubMed ID: 8989332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of trimethoprim/sulfamethoxazole in experimental Escherichia coli bacteremia and meningitis.
    Kim KS; Anthony BF
    Chemotherapy; 1983; 29(6):428-35. PubMed ID: 6360577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of trimethoprim-sulfamethoxazole injection in two infusion fluids.
    Lesko LJ; Marion A; Ericson J; Siber GR
    Am J Hosp Pharm; 1981 Jul; 38(7):1004-6. PubMed ID: 7258196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of trimethoprim-sulfamethoxazole in the treatment of chest infections.
    Hughes DT; Russell NJ
    Rev Infect Dis; 1982; 4(2):528-32. PubMed ID: 7051245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.
    Mylotte JM; Bates TR; Sergeant KA; Matson RE; Beam TR
    Antimicrob Agents Chemother; 1981 Jul; 20(1):81-7. PubMed ID: 7025751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of cotrimoxazole sulphonamide in malnourished (marasmic) infants.
    Bravo IG; Bravo ME; Plate G; Merlez J; Arancibia A
    Pediatr Pharmacol (New York); 1984; 4(3):167-76. PubMed ID: 6436778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of trimethoprim-sulfamethoxazole in the treatment of serious hospital-acquired bacterial infections.
    Quintiliani R; Levitz RE; Nightingale CH
    Rev Infect Dis; 1987; 9 Suppl 2():S160-7. PubMed ID: 3554454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state pharmacokinetics of sulfamethoxazole and trimethorprim in man after rectal application.
    Liedtke R; Haase W
    Arzneimittelforschung; 1979; 29(2):345-9. PubMed ID: 582148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic aspects of 2 modes of prevention of urinary tract infection in children with trimethoprim-sulfamethoxazole].
    Labbé J
    Can Med Assoc J; 1984 Nov; 131(10):1229-33. PubMed ID: 6498674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of experimentally induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo.
    Black RE; Levine MM; Clements ML; Cisneros L; Daya V
    Rev Infect Dis; 1982; 4(2):540-5. PubMed ID: 7051247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
    Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
    Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.